The ultimate purpose of pharmaceuticals is to improve patient health and quality of life. The industry therefore is responsible for ensuring its operational impact is mitigated as much as possible, this includes its environmental impact. The work our industry does is vital, but nonetheless these operations should be carried out in a responsible way to minimise any potential negative impacts.

The most significant impact on the environment comes from commercial scale pharmaceutical manufacturing.

As such, the pharma industry has been working on resolving this for many years, exploring more sustainable manufacturing processes wherever possible.

In an interview with On Drug Delivery, Erik Haeffler, Vice President Manufacturing Services & Head of Sustainability at Recipharm, discusses how the pharma industry can balance optimising environmental sustainability with maintaining the highest safety levels and ensuring continuous supply of vital medicines to patients.

You can read more by clicking the link to the article, here.